English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Effect of phospholipid hydrolysis by phospholipase A2 on the kinetics of antagonist binding to cardiac muscarinic receptors

Rauch, B., Niroomand, F., Messineo, F. C., Weis, A., Kübler, W., & Hasselbach, W. (1994). Effect of phospholipid hydrolysis by phospholipase A2 on the kinetics of antagonist binding to cardiac muscarinic receptors. Biochemical Pharmacology, 48(6), 1289-1296. doi:10.1016/0006-2952(94)90167-8.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : Effect of phospholipid hydrolysis by phospholipase A2 on the kinetics of antagonist binding to cardiac muscarinic receptors

Files

show Files
hide Files
:
BiochemPharmacol_48_1994_1289.pdf (Any fulltext), 686KB
 
File Permalink:
-
Name:
BiochemPharmacol_48_1994_1289.pdf
Description:
-
OA-Status:
Visibility:
Restricted (Max Planck Institute for Medical Research, MHMF; )
MIME-Type / Checksum:
application/pdf
Technical Metadata:
Copyright Date:
-
Copyright Info:
-
License:
-

Creators

show
hide
 Creators:
Rauch, Bernhard, Author
Niroomand, Feraydoon, Author
Messineo, Frank C., Author
Weis, Angelika, Author
Kübler, Wolfgang, Author
Hasselbach, Wilhelm1, Author           
Affiliations:
1Emeritus Group Biophysics, Max Planck Institute for Medical Research, Max Planck Society, ou_1497712              

Content

show
hide
Free keywords: cardiac muscarinic receptors; phospholipase A2; sarcolemma; quinuclidinyl benzilate; antagonist binding; binding kinetics
 Abstract: Activation of phospholipases during prolonged myocardial ischemia could contribute to the functional derangement of myocardial cells by altering the phospholipid environment of a number of membrane bound proteins including receptors. The present study examined the kinetics of muscarinic receptor antagonist [3H] quinuclidinyl benzilate binding ([3H]QNB) to muscarinic receptors of highly purified sarcolemmal membranes under control conditions and after treatment with phospholipase A2 (PLA2; EC 3.1.1.4.). Initial binding rates of QNB exhibited saturation kinetics, when plotted against the ligand concentration in control and PLA2 treated sarcolemmal membranes. This kinetic behaviour of QNB−binding is consistent with at least a two step binding mechanism. According to this two step binding hypothesis an unstable intermediate receptor−QNB complex (R*QNB) forms rapidly, and this form undergoes a slow conversion to the high affinity ligand−receptor complex R−QNB. The Michaelis constant Km of R−QNB formation was 1.8 nM, whereas the dissociation constant Kd obtained from equilibrium measurements was 0.062 nM. After 5 min exposure of sarcolemmal membranes to PLA2QNB binding capacity (Bmax) was reduced by 62%, and the affinity of the remaining receptor sites was decreased by 47% (Kd = 0.116 nM). This PLA2−induced increase of Kd was accompanied by a corresponding increase of Km, whereas the rate constants k2 and k−2 of the hypothetical slow conversion step (second reaction step) remained unchanged. These results suggest that binding of QNB to cardiac muscarinic receptors induces a transition in the receptor−ligand configuration, which is necessary for the formation of the final high affinity R−QNB complex. PLA2−induced changes of the lipid environment result in the inability of a part of the receptor population to undergo this transition, thereby inhibiting high affinity QNB−binding

Details

show
hide
Language(s): eng - English
 Dates: 1993-07-081994-04-121994-09-15
 Publication Status: Issued
 Pages: 8
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Biochemical Pharmacology
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: Amsterdam, Boston : Elsevier
Pages: - Volume / Issue: 48 (6) Sequence Number: - Start / End Page: 1289 - 1296 Identifier: ISSN: 0006-2952
CoNE: https://pure.mpg.de/cone/journals/resource/954925384102